Structured Summary
Abstract
Rare autosomal dominant syndrome characterized by mesenchymal and epithelial neoplasms at multiple sites. MUTATION of the p53 tumor suppressor gene, a component of the DNA DAMAGE response pathway, apparently predisposes family members who inherit it to develop certain cancers. The spectrum of cancers in the syndrome was shown to include, in addition to BREAST CANCER and soft tissue sarcomas (SARCOMA); BRAIN TUMORS; OSTEOSARCOMA; LEUKEMIA; and ADRENOCORTICAL CARCINOMA.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
1 entry terms
- Li Fraumeni Syndrome
MeSH Record
Aspects Covered
34 allowable subheadings
Indexed with the subheadings blood, cerebrospinal fluid, chemically induced, classification, complications, diagnosis, diagnostic imaging, diet therapy, drug therapy, economics, embryology, enzymology, epidemiology, ethnology, etiology, genetics, history, immunology, metabolism, microbiology, mortality, nursing, parasitology, pathology, physiopathology, prevention & control, psychology, radiotherapy, rehabilitation, surgery, therapy, urine, veterinary, virology.
MeSH Record
History Note
92
MeSH Record
Previous Indexing
- Neoplasms (1982-1986)
- Neoplastic Syndromes, Hereditary (1987-1991)
- Syndrome (1982-1986)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Li-Fraumeni Syndrome. Medical Subject Headings (MeSH). 2026. Unique ID D016864. http://id.nlm.nih.gov/mesh/2026/D016864
- Li-Fraumeni Syndrome. In: Wikipedia. https://en.wikipedia.org/wiki/Li%E2%80%93Fraumeni_syndrome
- Li-Fraumeni Syndrome. In: Wikidata. https://www.wikidata.org/wiki/Q187542